MARKET

MESO

MESO

Mesoblast
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.12
-0.08
-1.29%
Closed 16:00 11/12 EST
OPEN
6.25
PREV CLOSE
6.20
HIGH
6.25
LOW
6.08
VOLUME
10.78K
TURNOVER
--
52 WEEK HIGH
7.59
52 WEEK LOW
3.350
MARKET CAP
606.03M
P/E (TTM)
-6.7142
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MESO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MESO News

  • Cantor Fitzgerald Assumes Mesoblast at Overweight, Announces $23 Price Target
  • Benzinga.10/22 13:32
  • The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
  • Benzinga.10/17 11:39
  • Mesoblast, Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast's Potential First United States Allogeneic Cell Therapy
  • Benzinga.10/17 08:08
  • Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblasts Potential First United States Allogeneic Cell Therapy
  • GlobeNewswire.10/16 23:17

More

Industry

Biotechnology & Medical Research
+0.45%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About MESO

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
More

Webull offers Mesoblast limited (MESO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.